Virpax Pharmaceuticals, Inc. Share Price
Equities
VRPX
US9282512063
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | +6.22% | -15.76% | -3.16% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.63M 291M |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.36B | Net income 2025 * | -22M -1.76B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.38
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.28% |
1 day | +6.22% | ||
1 week | -15.76% | ||
Current month | -27.25% | ||
1 month | -20.10% | ||
3 months | -0.03% | ||
6 months | -58.11% | ||
Current year | -3.16% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 31/12/16 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 31/07/17 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 19/06/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 31/07/17 |
Jeffrey Gudin
FOU | Founder | 58 | 31/12/16 |
Director/Board Member | - | 23/03/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.1 | +6.22% | 5,246 |
25/04/24 | 2.918 | -7.94% | 8,353 |
24/04/24 | 3.17 | +0.32% | 4,665 |
23/04/24 | 3.16 | -4.24% | 11,455 |
22/04/24 | 3.3 | -10.33% | 16,065 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.16% | 3.63M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VRPX Stock